Mangrove Partners’s OSR Health Warrant OSRHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-204,072
Closed -$2.2M 180
2024
Q2
$2.2M Hold
204,072
0.17% 82
2024
Q1
$2.18M Hold
204,072
0.15% 97
2023
Q4
$2.14M Hold
204,072
0.14% 107
2023
Q3
$2.12M Hold
204,072
0.16% 116
2023
Q2
$2.09M Sell
204,072
-209,678
-51% -$11.7K 0.15% 140
2023
Q1
$4.18M Buy
+413,750
New +$28.9K 0.27% 129

Other funds holding OSRHW

Mangrove Partners's OSRHW Position: Q3 2024 in Review

Mangrove Partners sold out of OSR Health Warrant (OSRHW) in Q3 2024, closing a stake of 204,072 shares — an estimated $2.2M sold.

Mangrove Partners first reported a position in OSRHW in Q1 2023 and held it in 6 quarters. The position peaked at $4.18M in Q1 2023. 26 funds tracked by Wall St. Rank hold OSRHW as of Q3 2024.

  • Mangrove Partners reported no remaining OSR Health Warrant position as of Q3 2024 after selling out during the quarter.
  • Mangrove Partners sold 204,072 OSR Health Warrant shares in Q3 2024, an estimated $2.2M.
  • Mangrove Partners first reported a position in OSR Health Warrant in Q1 2023 and held it in 6 quarters.
  • Mangrove Partners's OSR Health Warrant position peaked at $4.18M in Q1 2023.
  • 26 funds tracked by Wall St. Rank held OSR Health Warrant as of Q3 2024.

Based on Mangrove Partners's 13F filing for Q3 2024, filed 14 Nov 2024.